series-c-plus
Stage
2020
Founded
2
Investors
About
Magnus Medical develops and commercializes the SAINT Neuromodulation System, an FDA-cleared, non-invasive treatment for major depressive disorder that uses personalized brain imaging to target precise neurostimulation over five days.
Explore Magnus Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.